// App-Quantinova.ai

2218 : Frailty Is Associated with Serious Infections in Biologic and Targeted-synthetic DMARD Treated Patients with Rheumatoid Arthritis

Researchers

Presenter

  • Namrata Singh

Principal Investigators

  • Laura Gold

  • Katherine Wysham

  • James Andrews

  • Pankti Reid

  • Una Makris

  • Bryant England

  • Jiha Lee

  • Michael George

  • Joshua Baker

  • Jeffrey Jarvik

  • Patrick Heagerty

  • Siddharth Singh

Medical Centers

  • University of Washington, Seattle, WA

  • University of Washington, Seattle, WA

  • VA-Puget Sound/University of Washington, Seattle, WA

  • The University of Chicago Medical Center, Chicago, IL

  • UT Southwestern Medical Ctr at Dallas, Dallas, TX

  • University of Nebraska Medical Center, Omaha, NE

  • University of Michigan, Ann Arbor, MI

  • University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania and Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA

  • University of California-San Diego, San Diego, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

  • Abatacept

  • Rituximab

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved